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Abstract
PchB is an isochorismate-pyruvate lyase from Pseudomonas aeruginosa. A positively charged
lysine residue is located in a flexible loop that behaves as a lid to the active site, and the lysine
residue is required for efficient production of salicylate. A variant of PchB that lacks the lysine at
residue 42 has a reduced catalytic free energy of activation of up to 4.4 kcal/mol. Construction of a
lysine isosteric residue bearing a positive charge at the appropriate position leads to the recovery
of 2.5–2.7 kcal/mol (about 60%) of the 4.4 kcal/mol by chemical rescue. Exogenous addition of
ethylamine to the K42A variant leads to a neglible recovery of activity (0.180 kcal/mol, roughly
7% rescue), whereas addition of propylamine caused an additional modest loss in catalytic power
(0.056 kcal/mol, or −2% loss). This is consistent with the view that (a) the lysine-42 residue is
required in a specific conformation to stabilize the transition state and (b) the correct conformation
is achieved for a lysine-mimetic sidechain at site 42 in the course of loop closure, as expected for
transition-state stabilization by the side chain ammonio-function. That the positive charge is the
main effector of transition state stabilization is shown by the construction of a lysine-isosteric
residue capable of exerting steric effects and hydrogen bonding but not electrostatic effects,
leading to a modest increase of catalytic power (0.267 – 0.505 kcal/mol of catalytic free energy, or
roughly 6 – 11% rescue).
Chemical rescue experiments have been widely used in enzymology studies to obtain insight
into the function of important active site amino acid sidechains (1). Non-covalent rescue
experiments usually include mutation of the residue of interest to an alanine and the addition
of excess compound mimicking the lost side chain (e.g. propylamine to mimic a lysine as
depicted in Scheme 1A and 1B). The first chemical rescue, by Toney and Kirsch, restored
activity in a lysine-to-alanine variant of aspartate aminotransferase using aliphatic amines as
the rescue agents (2, 3). Since then, a variety of amino acid variants that suffered loss of
activity have restored activity in the presence of exogenous compounds, including but not
limited to lysine to alanine or cysteine variants rescued with aliphatic amines (4–7), arginine
to alanine variants rescued with guanidinium or imidazole (8–13), histidine to glycine or
alanine variants rescued with imidazole (14–17), and an aspartate to serine variant rescued
with acetate (18). These experiments have sometimes been called “cavity mutants” as the
exogenous rescue agent is thought to bind in the cavity generated by the mutational variation
(19). Binding of the rescue agent in the vacated site has been confirmed crystallographic
*corresponding author: phone: (785)864-5075; fax: (785)864-5294; lamb@ku.edu.
Supplemental Information
The supplemental materials, which may be accessed free of charge online at http://pubs.acs.org, include: 1) Table S1 – a complete
table of the catalytic constants of all controls and variants discussed in this work. 2) Figure S1 – circular dichroism spectra of the
variants with and without the bromoethylamine modification. 3) Figure S2 – calculations based on the work of Richard and colleagues
(50, 51) demonstrating a lack of activation of K42A-PchB variant by the addition of exogenous propylamine.
NIH Public Access
Author Manuscript
Biochemistry. Author manuscript; available in PMC 2013 September 25.
Published in final edited form as:













studies of myoglobin (14) and trypsin (18). However, the exogenous rescue agent does not
always bind in the cavity, as in the case of carbonic anhydrase, where the rescue agent
reestablished a hydrogen bonding network by binding in a site remote to the mutation (15).
Alternatively, mutation of the residue of interest to cysteine allows for covalent chemical
modification by alkylating agents (e.g. bromoethylamine to generate γ-thialysine, Scheme
1C). Covalent modification may allow for better control over the position and orientation of
the rescue mimetic, with the caveat that any other reactive cysteines may be modified as
well. Covalent modification has been shown to be effective in a variety of systems,
including acetoacetate decarboxylase (20), ketopantoate reductase (7), fructose 1,6-
bisphosphate aldoloase (21), glutamine synthase (22), arginase I (23), and aspartate
aminotransferase (24, 25).
The enzyme under study here is the isochorismate-pyruvate lyase from Pseudomonas
aeruginosa (PchB). PchB is a structural homolog of the E. coli chorismate mutase (26), and
indeed has adventitious chorismate mutase activity, although the efficiency of the reaction is
lower (27, 28). The chorismate mutase reaction is pericyclic, with concerted but
asynchronous bond breaking and bond forming and a cyclic transition state (29). The
isochorismate-pyruvate lyase activity has been shown by NMR to occur via a quantitative
hydrogen transfer from C2 to C9, which led to the hypothesis that this reaction is also
pericyclic with the hydrogen atom as one of the atoms of the cyclic transition state (Scheme
2) (30). The hypothesis was supported computationally (31).
In our investigations of the pericyclic reactions catalyzed by the isochorismate-pyruvate
lyase from Pseudomonas aeruginosa (PchB), we have provided evidence that catalytic
power is derived from the organization of the substrate in the active site and from a positive
charge at the 42 site of the mobile active site loop. This hypothesis has a basis in three
previous experiments: 1) mutational analyses showed that variants at the K42 site did not
alter the active site architecture but a change in the chemical nature of the sidechain from
positively charged to neutral or negatively charged reduced or abolished activity (28); 2) pH
titrations of the K42H variant of the enzyme showed that with a protonated histidine at the
42 site the enzyme had nearly full activity whereas a deprotonated histidine at the same site
was an inefficient catalyst (32); and 3) thermodynamic data suggested that organization of
the substrate in the active site does not account for the observed entropic change thereby
implicating loop organization in catalysis (33). With these data in mind, we performed
several chemical rescue experiments. It is important to note that since the reaction is
pericyclic, the lysine of interest is not involved in a proton transfer (general acid-base
chemistry), does not participate in a covalent intermediate, nor is it a metal ligand as
frequently evaluated by chemical rescue. Instead, K42 is the residue of debate in the
controversy over electrostatic transition state stabilization versus reactive substrate
destabilization in the structurally homologous E. coli chorismate mutase. This lysine residue
(or the comparable arginine in the B. subtilis chorismate mutase) has been hypothesized to
be important either in stabilizing the developing negative charge of the ether oxygen at bond
breaking (34–41) or to be unimportant in catalysis (42–46).
The first chemical rescue experiment described was to determine if exogenous rescue agents
in a K42A variant were sufficient for restoration of activity, which might suggest that the
aliphatic amine could bind in a preformed cavity vacated by the variant sidechain. This
hypothesis seemed unlikely as the variant sidechain is found in the mobile active site loop
that undergoes a disorder to order transition upon binding of ligands in the active site, as
evidenced by crystallography (Figure 1) (26). In the second series of experiments, the K42C
and C7A,K42C variants were generated and tested for restoration of activity after treatment
with bromoethylamine, which generates a lysine mimetic, or treatment with bromoethanol,
which generates an isosteric alcohol (Scheme 1D). We hypothesized that restoration of
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activity would be more efficient in covalent rescue experiments. The comparison of the
amine versus alcohol derivatives was to consider the importance of a positive charge and/or
hydrogen bond donors/acceptors at the 42 site. We report our findings here.
EXPERIMENTAL PROCEDURES
Protein preparation
Wildtype and K42A-PchB were prepared as previously described (26). Site directed mutants
of PchB were prepared with the plasmid used for wildtype PchB overexpression as the
template and Quickchange II (Agilent) mutagenesis kit, using the protocol as per
manufacturer’s instructions. The K42C mutation was generated using a primer of sequence
5′-GGCGTCGCGCTTCTGCGCCAGCGAGGCGG-3′ (mutated codon is underlined) and
its reverse complement. The C7A mutation was generated using a primer of sequence 5′-
AACTCCGAAGACGCCACCGGCCTGGCG-3′ (mutated codon is underlined) and its
reverse complement. In order to prevent disulfide bond formation and aggregation of the
mutants which generated a new cysteine, 20mM β mercapto-ethanol was added to the
resuspension buffer. All buffers used in the purification process, including 30Q and gel
filtration buffers contained 1mM TCEP (Sigma).
Preparation of isochorismate
Isochorismate was prepared as described previously (28).
Enzymatic assays
All assays were performed using a TgK Scientific Stopped Flow device operated at 20 °C,
with a xenon lamp with the monochromator set at 310 nm, and a 360 nm cutoff filter. Equal
50μl volumes of enzyme and substrate were injected into a 22 μl cell and initial velocity of
salicylate production was measured as an increase in fluorescence at 430 nm for 30 seconds
during which the reaction was linear. Pre-injection enzyme and substrate concentrations
were twice the final enzyme/substrate concentration in the cell (post mixing). Unless
otherwise specified, all concentrations reported are final post-mixing concentrations. Both
the substrate isochorismate and enzyme were prepared in the same buffer system to prevent
buffer dilution effects post mix (50 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol, 1 mM
TCEP, and 500 mM rescue agent [where applicable]). Isochorismate was prepared to a
desired pre-mix final concentration of 0 – 800 μM. Enzyme concentrations used were 100
nM for wildtype and C7A-PchB experiments and samples treated with bromoethylamine,
and 2.5 μM for K42A-PchB, and 5 μM for PchB-K42C and C7A,K42C and samples treated
with bromoethanol. Michaelis-Menten kinetic data were fit using Kaleidagraph (Synergy
Software) using non-linear regression.
Covalent chemical rescue of K42C- and C7A,K42C-PchB variants with bromoethylamine
and bromoethanol
PchB variants and controls were incubated for 22–24 hrs at 18° C in 2.5 mL of 1 M Tris pH
8.8 with and without 1 mM bromoacylating reagent added. Enzyme was concentrated using
microcon centrifuge concentrators, and unreacted alkylating agent was removed by buffer
exchange into 50 mM Tris HCl pH 8.0, 150mM NaCl, 10% Glycerol, 1mM TCEP using a
PD-10 desalting column (GE Healthcare) as per manufacturer’s specifications. Protein
concentration was determined by Bradford assay. Enzyme was added to 10 mL of reaction
buffer without bromoacylating agent to final concentration of 200 nM – 10 μM (twice the
post-mix enzyme concentration). Substrate was prepared with the same buffer components.
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CD spectra of wild-type and variant PchB enzymes (~10 μM protein in 20 mM potassium
phosphate, pH 7.0) with and without modification with bromoethylamine were measured
with a Jasco J-815 spectrometer (Easton, MD) at 25 °C with a path length of 1 cm. Spectra
were recorded three times for each sample and averaged. The step size and bandwith were 1
nm and the averaging time at each wavelength was 1 s.
Ellman’s Reagent competition assay
In order to determine whether the cysteine at position 7 was solvent accessible and thus
alkylatable, 1 mL of 1 mM protein sample (wildtype, K42C-, C7A- or C7A,K42C-PchB)
was incubated for 24 hours at 18 °C in the same buffer used in the alkylation process as
described above, but without alkylating reagent. A volume of 100 μl of each of the samples
was reacted with 1 mM 5,5′-Dithio-bis(2-nitrobenzoic acid) (DTNB or Ellman’s reagent) in
300 mM Tris pH 8.0, 25 mM sodium acetate buffer for 5 minutes at room temperature.
Absorbance was measured at 412 nm and concentration of NTB−2 was determined (ε =
13600 M−1 cm−1) (47). For these experiments, protein concentration was determined by
measuring the absorbance at 280 nm and using the extinction coefficient calculated by
ProtParam (ε= 20,970 M−1 cm−1) (48). This concentration corresponds to a 1:1 ratio with
the solvent accessible cysteines in solution. Wildtype (one cysteine at position 7) and C7A-
PchB variant (no cysteines in sequence) showed no change in absorbance, indicating no
cysteines are solvent accessible in these enzymes. K42C- (two cysteines at positions 7 and
42) and C7A,K42C-PchB (one cysteine at position 42) both showed a similar absorbance
change corresponding to one cysteine per protein molecule being solvent accessible.
Presumably, this is cysteine at position 42, since the cysteine at position 7 is not accessible
in the wildtype and only one cysteine is accessible in the K42C-variant; however, it is
possible that both cysteines are modified at 50% efficiency in the K42C-variant. Samples of
each enzyme were then incubated as described above for the controls but with excess
alkylating agent (10 mM). A DTNB competition assay was performed to determine the
percent alkylation for bromoethylamine and bromoethanol using the equation
(1)
Wildtype and the C7A-variant showed no alkylation (0%). K42C-PchB showed 82%
alkylation for two cysteines. C7A, K42C-PchB showed 98% alkylation for 1 cysteine with
derivatization with bromoethylamine, and 100% alkylation for 1 cysteine with derivatization
with bromoethanol. The values (% alkylation) were used to adjust the kinetic parameters
found in Tables 1 and 2.
ΔΔG‡ Calculations
To quantify chemical rescue, variant effects were calculated in terms of changes in energies
of activation:
(2)
where R represents the gas constant (1.98×10−3 kcal K−1 M−1) and T is the experimental
temperature, 293 K (20°C). Propagation of the error of kcat/Km to the ΔΔG‡ was calculated
as described previously (49) using equation 3.
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Kinetic measurements of isochorismate pyruvate lyase activity
The experiments presented were conducted in a new buffer system from previously reported
work and the experiments were performed using a stopped-flow spectrometer. While the
values are different by three-fold from those previously reported (28), the K42A-PchB
variant was shown previously to have 100-fold reduction in kcat/Km relative to wildtype,
which is consistent with the values presented in Table 2.
Attempted chemical rescue of K42A-PchB with exogenous alkylamines
The K42A-PchB variant was employed to further gauge the catalytic contribution of the
sidechain at this position by determining the rescue efficiency in the presence of exogenous
amines. Figure 2 shows the effect of exogenous amines on specific activity of wildtype and
K42A-PchB. Since the molecular void volume created by the formation of the K → A
variant is the same as that of propylamine (4, 7), this compound was used for an initial
analysis. Panel A shows the effect of increasing propylamine concentration on lyase activity
for wildtype (circles) and K42A-PchB (squares). If there were rescue, then we would expect
a hyperbolic curve. Instead, a line with a slope of 0 is shown at the value of activity without
exogenous amine added. Methylamine, ethylamine and butylamine were also tested at a
single concentration of 0.5 M with no rescue seen for these alkylamines of smaller or large
molecular volume (Figure 2B). The effective binding constants for these compounds must
be higher than two-fold the highest concentration tested, giving a minimum Kd of 2 M. All
of the alkylamines showed a specific activity that was within 1.3-fold the specific activity of
the K42A-PchB variant without exogenous amine.
Attempted chemical rescue of K42A-PchB with exogenous ethylamine or propylamine
Michaelis-Menten kinetic analyses of K42A-PchB with 0.5 M ethylamine or 0.5 M
propylamine were carried out. A comparison of the kinetic parameters for wildtype and the
K42A-PchB variant is found in Table 1. The K42A-PchB variant has altered values for both
kcat and Km relative to wildtype. The kcat value is reduced by 2.9-fold, and the Km is
increased by 27-fold, suggesting that the lysine at the 42 site is important in substrate
binding. The rate of enhancement upon the addition of ethylamine or propylamine is
compared relative to the variant. K42A-PchB in the presence of either ethylamine or
propylamine demonstrates a 2-fold increase in kcat relative to K42A-PchB without
exogenous amine. There was a comparable change in Km. The change in the Km may
suggest that the lysine has a role in binding substrate, but the addition of the exogenous
amine does not rescue substrate binding. A comparison of the kcat/Km values (Table 2)
shows the lack of rescue more clearly. The kcat/Km values for K42A-PchA with and without
exogenous amine are all approximately 100-fold less than the wildtype value. The addition
of ethylamine to K42A-PchB increased the kcat/Km by 1.4-fold relative to the variant
without exogenous amine, whereas propylamine reduced the value by 0.9-fold.
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Successful chemical rescue of K42C-variants PchB by construction of an isosteric γ-
thialysine at position 42 with bromoethylamine
A K42C-PchB variant was generated and modified by reaction with bromoethylamine to
form γ-thialysine (Scheme 1C) at any solvent accessible cysteines. The K42C-PchB variant
shows an increased Km relative to wildtype, presumably due to the loss of the hydrogen
bond donor or positive charge at this site (Table 1). The Km values for K42C-PchB with the
modification to make the lysine mimetic shows a decrease in the Km by nearly 6-fold.
However, when the K42C-PchB is modified with the bromoethylamine, the kcat shows a
11.4-fold increase relative to the unmodified variant. The change in both values represent a
significant rescue of activity by the lysine mimetic. Indeed, the kcat/Km increases 68-fold
(Table 2).
A double mutant was generated to remove the naturally occurring cysteine from the N-
terminus of the protein, thereby generating a C7A,K42C-PchB double variant. In the
absence of rescue agent, the double variant showed kinetic parameters comparable to the
single variant (Table 1). With the formation of the lysine mimetic, the C7A,K42C-variant
kcat value was again rescued significantly (12-fold) and in this case, the Km value was
decreased by ~8-fold. Rescue is even more evident in this variant with a kcat/Km value that
is 103-fold higher than the variant without the modification to make the lysine mimetic.
Attempted chemical rescue of K42C- PchB and C7A,K42C- PchB by construction of an
isosteric γ-thia-ω-oxa-lysine at position 42 with bromoethanol
The K42C- PchB variant and the C7A,K42C- PchB double variant were also modified with
bromoethanol to generate the isosteric alcohol residue (Scheme 1D). These modified
variants showed no rescue in kcat, showing values within 2.2-fold of the unmodified variant,
and demonstrated Km value within a 1.1-fold of the unmodified variant (Table 1). Indeed,
the kcat/Km values are ~2-fold higher than the variant without the modification (Table 2).
Secondary structure maintained as detected by circular dichroism spectroscopy
Circular dichroism spectroscopy was used to assess the secondary structure of the variant
proteins with and without modification by bromoethylamine. All variant proteins were
found to be comparable to wild type with strong minima at 208 and 212 nm, characteristic of
helical structure (Supplement Figure 1). The variants that contained the cysteine to alanine
change at the seven position may exhibit a slightly lower helical property than those with the
native cysteine. Modification of the proteins with bromoethylamine had no impact of
helicity (open versus closed symbols).
DISCUSSION
Recent work by Richard and colleagues on triosphosphate isomerase (50) and orotidine 5′-
monophosphate decarboxylase (51) provides a framework for reporting and interpreting
chemical rescue experiments. In both enzymes, a cationic sidechain (lysine12 and
arginine225, respectively) is adjacent to a flexible phosphodianion gripper loop, and the
sidechain forms a stabilizing ion pair with the substrate. Excision of the sidechain results in
a large decrease in catalytic activity (104 to 105-fold). A substantial fraction of the catalytic
activity for the variants is rescued by addition of exogenous guanidine or alkyl ammonium
cations. In the work on these two enzymes, elegant calculations are used to determine the
effective molarity of the sidechain and the related free energies of activation: ΔG‡rescue agent
represents the portion that can be rescued by the activator, and ΔG‡S represents the
advantage of having the two pieces connected, called the “connection energy.” In these
previous examples,
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where ΔG‡rescue agent is negative, and with the connection energy (ΔG‡S) sums to give the
variational effect caused by mutation at the site in question (ΔG‡variant − ΔG‡WT). In the
best case scenario, a simple model provides an estimate of the entropy advantage caused by
fusing the rescue agent to the sidechain. Richard and colleagues (50) also provide enthalpic
arguments, stating that the connection energy is an “empirical” transition state stabilization:
there may be an enthalpic penalty due to desolvation or an enthalpic advantage due to
binding interactions. The former case would be evident as a large effective molarity, since
desolvation of the sidechain is already “paid” in the folding of the enzyme. An enthalpic
advantage from favorable binding interactions between the rescue agent and the protein is
evidenced by a small effective molarity (50).
In PchB, the site in question is the 42 position, which is located in a flexible loop as
determined by crystallography (Figure 1). No electron density is observed for residues 42–
48 in the wildtype structure with an open active site (26). The open structure further shows
that there is no pre-formed binding site for exogenous amines in this conformation. The
structure of the K42A-PchA variant shows a hole in the solvent accessible surface of this
“closed” conformation where the lysine sidechain is no longer present, highlighting the site
where an exogenous amine would need to bind and be organized after ordering of the loop
(Figure 1). This “binding site” for exogenous amines presumably has a Kd > 2 M, since no
rescue was observed at concentrations up to 1 M. Previous determination of the activation
thermodynamics of the reaction suggested at the importance of loop organization for PchB
lyase activity (33). Therefore, organization of the loop upon active site closure must also
organize the lysine sidechain and lead to the formation of the transition state.
If Richard’s calculations are applied to the K42A-PchB protein and the rescue attempts with
exogenous propylamine (Supplemental Figure S2), the effective molarity of the sidechain at
lysine42 is 610 M, suggesting that if the experiments could be conducted at this
concentration of propylamine, the variant would turn over at the same rate as wildtype. The
effective molarity in the PchB experiments is within the range of those presented previously
(50, 51), which would suggest no evidence for an enthalpic disadvantage due to desolvation.
We suggest that desolvation of the rescue agent and the mobile sidechain in the flexible
active site loop would be comparable. The sidechain is exposed to solvent in the ground
state open conformation and becomes desolvated and buried upon active site closing, which
is true regardless of whether or not the sidechain is covalently attached. Furthermore, as
mentioned above, we estimate that the Kd is > 2 M, since no rescue was observed for
concentrations up to 1 M. In other words, there is not tight binding of the rescue agents to
PchB, since there is not a preformed cavity for binding in the ground state. A portion of the
binding interactions may be required to hold the loop in the closed conformation in the
transition state. Such an interaction would not be rescued by an exogenous amine, but would
require a covalent connection between the amino acid sidechain and the enzyme. Indeed, the
connection energy in the transition state (ΔG‡S) is calculated from the effective molarity to
be 3.8 kcal/mol, which is greater than the value for the variational effect between the K42A-
and WT-PchB, ΔG‡K42A − ΔG‡WT, determined to be 3.4 kcal/mol. In keeping with this
result, the 1/Kd‡ for propylamine can be determined and the ΔG‡PrA calculated, giving a
value of 0.4 kcal/mol (positive, not negative as previously seen). While these values are
internally consistent, this analysis highlights the inability to rescue by an exogenous amine.
A different analysis is desirable for PchB to account for the placement of the amino acid to
be rescued in the flexible loop and for direct comparison with covalent rescue agents.
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We propose that variational effects in chemical rescue experiments can be calculated more
directly from the (apparent) kcat/Km in terms of differences in the free energies of activation
(ΔΔG‡, Table 2). The difference in energies can be calculated using equation 2, such that
the mutational effect of replacing the wildtype lysine at position 42 with an alanine
(effectively removing steric and charge effects) increases the free energy of activation as
compared to the wildtype lyase activity by 2.56 kcal/mol (Table 2 entry 1b). This number
represents the maximal change in free energy of activation that any given exogenous
chemical would be able to rescue to reach activity levels comparable to wild type enzyme.
Addition of excess exogenous positive charge in the form of ethylamine does not rescue
catalytic activity (−0.18 kcal/mol or 7% rescue of the mutational effect; Table 2 entry 2a).
The addition of propylamine causes a further reduction in activity (0.056 kcal/mol, or −2%
of the mutational effect; Table 2 entry 2b). Addition of alkylamines of different carbon chain
length (methyl- or butylamine) at the same concentration did not rescue catalysis either
(Figure 2).
A K→C variant was generated at the 42 position, to enable introduction of a positive charge
with bromoalkylating compounds (Scheme 1C). As with the K→A mutation, the K42C
variant displayed an increased energy of activation, in this case by 4.4 ± 0.1 kcal/mol (Table
2, entry 3b). This increase in ΔΔG‡ would correspond to a theoretically perfect rescue.
Indeed, the covalent modification of the K42C variant with bromoethylamine (generating a
γ-thialysine at this position), rescues 2.45 ± 0.06 kcal/mol, roughly 55% of the ideal rescue
(Table 2 entry 4a). However, wildtype PchB treated with bromoethylamine showed a
decrease in catalytic activity with a kcat/Km 2.4-fold lower (See Supplemental Table S1).
This may be due to the alkylation of a natural cysteine located near the N-terminus (position
7) of the enzyme. Removal of this cysteine through the generation of a C7A variant provides
better control over the effects of extraneous alkylation, and the kcat/Km value for C7A-PchB
is comparable to wildtype (0.7-fold change). The K42C variant over the C7A background
resulted in a 4.2 kcal/mol gain in energy of activation with respect to the C7A background
variant (Table 2 entry 3d). Treatment of this double variant with bromoethylamine
confirmed the results of the K42C single mutant experiments: generation of the γ-thialysine
results in a significant rescue. In the case of the double mutant, a 2.69 kcal/mol rescue (64%;
Table 2 entry 4b) of the possible ideal rescue of 4.2 kcal/mol is observed.
Previous work on the structural homolog Escherichia coli chorismate mutase had suggested
that a positive charge at the site equivalent to PchB 42 is not important for catalysis:
organization of the substrate carboxylates by arginines buried deep within the active site was
hypothesized to generate a near attack conformation which was sufficient for catalysis (42–
46). In order to test this hypothesis, a variant with a lysine-isosteric residue bearing a
hydroxyl group in lieu of the positively charged amino group was generated using
bromoethanol instead of bromoethylamine (Scheme 1D). A modest increase in activity was
observed for the K42C-PchB variant (0.505 ± 0.003 kcal/mol; 11%; Table 2 entry 5a) with
less observed in the C7A,K42C double variant (0.267 ± 0.005 kcal/mol; 6%; Table 2 entry
5b). Mutagenesis (28) and pH dependence (32) experiments have provided evidence that the
positive charge at position 42 is important for efficient catalysis. The ability to rescue
catalytic activity of the variants modified to produce a γ-thialysine at position 42, but not
through the generation of the hydroxyl derivative, gives further support to the importance of
electrostatic transition state stabilization in the isochorismate-pyruvate lyase reaction.
Structural (26) and thermodynamic (33) experiments have led to the hypothesis that loop
organization is important for catalysis. Indeed, this is supported by the ineffectiveness of the
ethylamine or propylamine to serve as a non-covalent chemical rescue reagents; the positive
charge must be organized with the loop for efficient catalysis. We propose that a positive
charge at position 42 and correct loop organization, including organization of the lysine at
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position 42, lead to efficient lyase catalysis, and give further support to the idea that
electrostatic transition state stabilization and loop dynamics work in concert for catalysis.
These data lead to the question of why the isosteric γ-thialysine at position 42 is less able to
promote catalysis than the native lysine or the previously tested histidine variant (32) at the
same site. The tested variants are all apparently properly folded and stable, and for those
modified by alkylation, the chemistry of modification was either complete or the kinetics
were adjusted by a small correction. The answer may be simply that the active site is better
able to accommodate the positively charged sidechains lacking sulfur; however, the
geometry of the lysine and γ-thialysine would place the positive charge in a more similar
position than that for histidine, which is effectively one methylene group shorter (in fairness,
we must note that the histidine variant has not been tested in the buffer system detailed in
this report). Alternatively, the answer may be in the role that the lysine plays in catalysis.
This amino acid is not involved in covalent catalysis or acid/base chemistry, but has been
proposed to stabilize the developing negative charge of the transition state in this pericyclic
reaction. In PchB, closing of the active site is integral to formation of the transition state
from the reactant state (33), and this requires organization of the active site loop and the
lysine at site 42. It is tempting to propose that the motion of the residue at the 42 site may
promote development of the negative charge on the ether oxygen of bond breaking. A
vibrational motion bringing the positively charge sidechain into proximity of the ether
oxygen of the substrate may be more easily achieved by lysine and histidine as compared to
the γ-thialysine.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Active site of PchB in the open and closed wildtype and closed K42A-PchB structures
Overlay of the wildtype closed (PDB: 3REM, purple), wildtype open (PDB: 2H9C, green)
and K42A –PchB (PDB: 3HGX, yellow) structures. The open structure, solved in the
absence of products, has no electron density for the active site loop, which connects the A
and B helices and contains a single turn of helix when ordered in the closed structures. The
amino acid at the 42 position, which is the first residue of the active site loop, is shown as
sticks, as is the amino acid at the 7 position from the opposing monomer (7′). The salicylate
and pyruvate from the closed structures are also shown as sticks, all colored like the cartoon.
The solvent accessible surface (grey) for the K42A structure shows a hole leading to the
active site, highlighting the location that a chemical rescue agent must bind and be
organized. Figure was generated with PyMOL (52).
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Figure 2. No chemical rescue of isochorismate-pyruvate lyase activity by exogenous amines
A. There was no recovery of K42A-PchB activity (□) with the addition of propylamine. The
value without the addition of exogenous amine is shown as a dashed line (86.2 nmol/min/
μg). Propylamine similarly had no effect on the activity of wildtype enzyme (○). The value
without the addition of exogenous amine is shown as a solid line (1370 nmol/min/μg). B.
The amine molecular volume was unimportant in the lack of rescue, because methylamine
(MeA), ethylamine (EtA), propylamine (PrA) and butylamine (BuA) were all equally
ineffective as chemical rescue agents at 0.5 M. Wild-type activity without exogenous amine
is shown as the upper solid lined (1370 nmol/min/μg) and with the addition of rescue agents
shown as circles (○). The activity of the K42A-PchB variant without exogenous amine is
shown as the lower dashed line (94.4 nmol/min/ng) and with the addition of rescue agents
shown as squares (□).
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Structures of the lysine at residue 42 of WT PchB (A), a lysine mimetic assembly with
propylamine (B), a lysine mimetic residue resulting from covalent modification of the
cysteine variant with bromoethylamine (C), and a lysine-isosteric residue lacking
electrostatic charge resulting from covalent modification of the cysteine variant with
bromoethanol (D).
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Isochorismate-pyruvate lyase activity catalyzed by PchB. The arginines that arrange the
substrate carboxylates (R14 and R31) are shown in grey, as is the lysine (K42) of interest in
this study, which is hypothesized to stabilize the developing negative charge of the transition
state.
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Table 1
Catalytic constants for wildtype PchB and variants at residue 42 with or without exogenously added
ethylamine or propylamine or covalent modification of the sidechain with bromoethylamine or bromoethanol.
Samplea kcat (×10−3 s−1) kcatvar/kcatctrl Km (μM) Kmvar/Kmctrl
WTb 130 ± 0 1.1 ± 0.1
 K42A 45 ± 1 1 30 ± 1 1
 K42A + EtA 83 ± 1 1.8 60 ± 1 2
 K42A + PrA 98 ± 1 2.2 48 ± 1 1.6
WTc 178 ± 1 1.39 ± 0.03
 K42C 8.28 ± 0.04 1 134 ±1 1
 K42C + BrEA 94.6 ± 0.1 11.4 23 ± 1 0.17
 K42C + BrEtOH 18.4 ± 0.1 2.2 125 ± 1 0.93
 C7A,K42C 8.96 ± 0.01 1 123 ± 2 1
 C7A,K42C + BrEA 105 ± 1 12 15.6 ± 0.3 0.13
 C7A,K42C + BrEtOH 12.8 ± 0 1.4 114 ± 2 0.93
 C7A 200 ± 10 2.10 ± 0.02
a
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